Although immunosuppressive treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis results in a 10-year survival rate of 60–90%, a substantial number of patients suffer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback